UNSPSC 51142509: Ropinirole
Commodity
Code facts
- Part of
-
-
51000000
-
51140000
- 51142500
-
51140000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51142509
Definition
This classification denotes an antiparkinsonian agent with the molecular formula C16H24N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 030PYR8953, chemically known as 4-(2-dipropylaminoethyl)-1,3-dihydroindol-2-one but generally known as ropinirole, which bears US NIH Compound Identifier 5095. European Medicines Agency schedules Ropinirole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10380MIG.
Read the full definition
The term ROPINIROLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). World Health Organization schedules ropinirole in its Anatomical Therapeutic Chemical (ATC) Classification. ROPINIROLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ropinirole under HS 29337900 and SITC 51561. As of Q4 2014, ROPINIROLE remains the US FDA Preferred Term for this commodity. Ropinirole bears US NLM identifiers UMLS ID C0244821 and NCI Concept Code C61931.
SMILES: O=C1NC2C(C(CCN(CCC)CCC)CCC2)C1.
About UNSPSC 51142509
UNSPSC 51142509 Ropinirole is a Commodity code nominally addressing a specific pharmaceutical product, but recent state and local solicitation activity under this code shows a marked mismatch — the single available opportunity involves procurement of naloxone and drug deactivation systems for community health support, not ropinirole itself. State and local governments soliciting under this code appear to be health departments and county community health offices seeking opioid-response and harm-reduction supplies on a recurring basis, typically through IFB or competitive sealed-bid processes with multi-year initial terms and renewal options.
Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The solicitation is an IFB with a response deadline of July 26, 2023, and includes a two-year initial contract term with a one-year renewal option. Vendors must include all shipping and delivery costs in their bids, hold required insurance coverages, comply with E-Verify, and meet drug-free workplace certification and federal compliance standards, including potential FEMA funding requirements. The code shows limited recent relevant activity, and the single opportunity does not align with the code's stated pharmaceutical scope, suggesting either miscoding in the state system or minimal demand for ropinirole-specific procurement through state and local channels.
Quick answers
What is UNSPSC 51142509?
UNSPSC 51142509 is Ropinirole, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51142509?
UNSPSC 51142509 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).
On GovTribe
See everything under UNSPSC 51142509
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code